ChineseChina UKUK DeutschlandDeutschland FranceFrance РоссияРоссия 한국한국 ไทยไทย Việt NamViệt Nam العربيةالعربية ҚазақстанҚазақстан EspañaEspaña MyanmarMyanmar DaiDai

Linking China’s Premium Healthcare · Serving Global Health Needs

Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties

One-Stop Medical Care in China

  • International flights · Airport pickup · Nearby hotels
  • Multilingual interpreters · Full medical escort
  • Expert matching · Hospital fast-track
  • Full-cycle treatment · Post-op follow-up
Sign in

Mr. John is suffering from lung cancer

Patient basic information Patient: Mr. John (John Brown) Nationality: Central Africa Diagnosis: Ovarian Cancer Clinical Hospital: H0ZH Treatment: Targeted Treatment + Immunity Treatment Holidays: 175 days Treatment cost: about 408054 yuan Treatment effect: Pain relief Upon arrival, the International Medical Services Team arranged for the first time multidisciplinary MDT clinics for patients, developed individualized clinical pathways based on the patient's examination reports and physical condition, and provided translation, guidance and on-site services throughout the treatment process. The MD2 team used a comprehensive set of targeted therapeutic+immunotherapies, with the medical team closely monitoring the patient's indicators and dynamic adjustment programs during the treatment process.

After 175 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and the test indicators returned to normal areas, successfully reaching the hospital standard. Treatment results: the patient's pain was finally relieved. At the time of his discharge, the medical team developed a detailed return follow-up and rehabilitation plan for him and continued to track recovery through the remote follow-up system.

The patient commented: 'We are impressed by the level of expertise of Chinese doctors and the condition of equipment at Chinese hospitals. 'Mr. John has criticized the case as a typical case of cross-border suspected seriousness clinical disease.

The multi-disciplinary collaborative mechanism for developing targeted treatment+immunotherapy for ovarian cancer reflects the comprehensive strength of Chinese hospitals in the field of suspected disease diagnostics and is a shorthand for the regulation of international visitor medical services.

中非,卵巢癌,广东省人民医院,国际医疗,来华就医,中国医疗